This project focuses on developing a software tool to help comprehend the impact of the time and size of an insulin bolus to regulate post prandial glucose excursion in blood for people with Type 1 ...
The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people with insulin-treated type 2 diabetes (T2D), a new randomized trial showed.
The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.
MADRID — Day of the week, age, snacking, and being more engaged with smart insulin pens are important factors that affect adherence to injecting bolus insulin in people living with diabetes (PLWD), ...
Real-world use of the MiniMed 780G (MM780G) system is associated with effective glycemic control on days when users do not administer bolus insulin, achieving a mean time in range of 70.9%. Real-world ...
COPENHAGEN, Denmark & PALO ALTO, Calif.--(BUSINESS WIRE)--Glooko, Inc. and Hedia today announced the launch of their interoperable solution, which combines connected care, remote patient monitoring, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results